statistiche ricercatore

Continente	#
EU - Europa	793
NA - Nord America	532
AS - Asia	309
SA - Sud America	102
Continente sconosciuto - Info sul continente non disponibili	35
AF - Africa	6
Totale	1.777

Nazione	#
US - Stati Uniti d'America	516
RU - Federazione Russa	408
SG - Singapore	133
IT - Italia	92
BR - Brasile	86
IE - Irlanda	80
SE - Svezia	73
CN - Cina	59
DE - Germania	33
HK - Hong Kong	29
VN - Vietnam	25
PL - Polonia	21
FR - Francia	14
FI - Finlandia	13
JP - Giappone	13
AT - Austria	12
IN - India	11
BD - Bangladesh	10
GB - Regno Unito	9
BE - Belgio	8
CA - Canada	7
ES - Italia	5
MX - Messico	5
ID - Indonesia	4
IQ - Iraq	4
PE - Perù	4
UA - Ucraina	4
VE - Venezuela	4
CZ - Repubblica Ceca	3
EC - Ecuador	3
LT - Lituania	3
MY - Malesia	3
NL - Olanda	3
PT - Portogallo	3
AR - Argentina	2
BY - Bielorussia	2
DO - Repubblica Dominicana	2
HU - Ungheria	2
IR - Iran	2
MA - Marocco	2
PH - Filippine	2
PK - Pakistan	2
SA - Arabia Saudita	2
TR - Turchia	2
AE - Emirati Arabi Uniti	1
BG - Bulgaria	1
BO - Bolivia	1
CH - Svizzera	1
CO - Colombia	1
EE - Estonia	1
EG - Egitto	1
EU - Europa	1
GE - Georgia	1
GR - Grecia	1
IL - Israele	1
JM - Giamaica	1
KZ - Kazakistan	1
MK - Macedonia	1
PS - Palestinian Territory	1
PY - Paraguay	1
QA - Qatar	1
TG - Togo	1
TH - Thailandia	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
UZ - Uzbekistan	1
XK - ???statistics.table.value.countryCode.XK???	1
ZA - Sudafrica	1
Totale	1.744

Nome	#
A Single Centre Experience with 223-Radium-Dichloride ((RaCl2)-Ra-223) Therapy	205
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience	204
PRRT Retreatments: Renal Function Evaluation	200
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer	187
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients	180
Effectiveness, safety and haematological toxicity of 223Ra-Cl2: a single centre experience	170
BRAF and RAS mutations in differentiated thyroid cancer of patients with low-risk to intermediate-risk treated with radioiodine therapy	151
Prognostic Validity of Dual Tracer PET/CT In The PRRT Enrollment of GEP-NET Patients	149
Artificial Intelligence Applications on Restaging [18F]FDG PET/CT in Metastatic Colorectal Cancer: A Preliminary Report of Morpho-Functional Radiomics Classification for Prediction of Disease Outcome	116
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature	115
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature	100
Totale	1.777

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	90	0	4	2	8	4	3	1	3	2	9	9	45
2022/2023	280	23	37	14	22	25	35	7	19	90	3	5	0
2023/2024	60	5	4	6	3	6	18	1	0	0	5	4	8
2024/2025	333	8	10	10	12	22	11	21	64	69	22	43	41
2025/2026	903	67	49	49	40	59	205	101	133	111	51	20	18
2026/2027	24	9	15	0	0	0	0	0	0	0	0	0	0
Totale													1.777